Literature DB >> 20382085

Microparticles induce variable levels of activation in macrophages infected with Mycobacterium tuberculosis.

Awadh B Yadav1, Pavan Muttil, Amit K Singh, Rahul K Verma, Mradul Mohan, Atul K Agrawal, Ajay S Verma, Sudhir K Sinha, Amit Misra.   

Abstract

Activation of human macrophages infected with Mycobacterium tuberculosis was investigated following exposure to microparticles (MP) possessing high anti-tubercular efficacy in mice. A small set of innate responses (cytokine profiles, NO production, Annexin-V staining and caspase-8, caspase-9 and caspase-3 activities) of differentiated THP-1 cells or human monocyte-derived macrophages infected 1:10 in vitro were compared. Cytokines of THP-1 macrophages were comparable in trends, but not in magnitude, with five human genotypes studied. MP reversed suppression of tumor necrosis factor induced by infection, and transiently upregulated gamma-interferon. Drug-free MP surprisingly induced gamma-interferon, but not tumor necrosis factor. Primary cells responded to MP, regardless of drug content, by upregulation of NO; but THP-1 cells did not respond to drug-free MP. About 19% of infected cells exposed to MP underwent apoptosis compared to approximately 11% cells treated otherwise. Cell death induced by drug-free MP was caspase independent. Intracellular bacterial survival varied between individuals. Untreated infection resulted in survival of 900+/-141 cfu; exposure to soluble drugs, drug-containing and blank microparticles respectively, reduced CFU counts to <10, <10 and 102+/-139. These observations indicate that despite variations in magnitude between cells from different sources, innate responses conducive to killing intracellular bacteria were evoked by inhalable MP. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20382085     DOI: 10.1016/j.tube.2010.03.001

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  5 in total

1.  Recent Developments in Drug Delivery for Treatment of Tuberculosis by Targeting Macrophages.

Authors:  Anirudh Gairola; Aaron Benjamin; Joshua D Weatherston; Jeffrey D Cirillo; Hung-Jen Wu
Journal:  Adv Ther (Weinh)       Date:  2022-03-09

2.  Understanding the Link between Inflammasome and Apoptosis through the Response of THP-1 Cells against Drugs Using Droplet-Based Microfluidics.

Authors:  Elif Gencturk; Muge Kasim; Berna Morova; Alper Kiraz; Kutlu O Ulgen
Journal:  ACS Omega       Date:  2022-05-02

Review 3.  Targeted pulmonary delivery of inducers of host macrophage autophagy as a potential host-directed chemotherapy of tuberculosis.

Authors:  Anuradha Gupta; Amit Misra; Vojo Deretic
Journal:  Adv Drug Deliv Rev       Date:  2016-01-29       Impact factor: 15.470

4.  Treatment of Mycobacterium tuberculosis-Infected Macrophages with Poly(Lactic-Co-Glycolic Acid) Microparticles Drives NFκB and Autophagy Dependent Bacillary Killing.

Authors:  Ciaran Lawlor; Gemma O'Connor; Seonadh O'Leary; Paul J Gallagher; Sally-Ann Cryan; Joseph Keane; Mary P O'Sullivan
Journal:  PLoS One       Date:  2016-02-19       Impact factor: 3.240

5.  Preparation and Preclinical Evaluation of Inhalable Particles Containing Rapamycin and Anti-Tuberculosis Agents for Induction of Autophagy.

Authors:  Anuradha Gupta; Deepak Sharma; Jairam Meena; Sanketkumar Pandya; Madhur Sachan; Sadan Kumar; Kavita Singh; Kalyan Mitra; Sharad Sharma; Amulya K Panda; Pushpa Gupta; Umesh Datta Gupta; Amit Misra
Journal:  Pharm Res       Date:  2016-04-19       Impact factor: 4.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.